Abstract:Objective To investigate the inhibition of adefovir dipivoxil (ADV ) against duck hepatitis B virus (DHBV ) cccDNA . Methods DHBV naturally infected Peikin ducks fed in Xi′an were used as the animal model and were treated orally with 10 mg · kg -1 of ADV daily for 30 days ,and 0 .5 mL of 0 .01 mol · L -1 PBS was used as the negative control .The levels of DHBV DNA in the peripheral blood were quantified at day 0 ,10 ,20 and 30 of the treatment and at day 15 after the termination of treat‐ment .The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were examined .Liver tissues of every duck in two groups were obtained by surgery ,and DHBV DNA and cccDNA were determined at day 30 of the treatment and at day 15 after the termination of treatment .Results The serum DHBV DNA levels in ADV treated ducks at day 10 ,20 and 30 of the treatment were significantly reduced as compared with those at baseline of treatment (P< 0 .05) ,and with prolonged treatment ,the serum DHBV DNA levels decreased gradually .At day 15 after the termination of treatment ,the serum DHBV DNA levels were still significantly lower than those at baseline of treatment (P< 0 .05) ,but the rebound of the levels of serum DHBV DNA in ADV treated ducks was observed .At day 20 and 30 of the treatment and day 15 after the termination of treatment ,the se‐rum DHBV DNA levels were significantly lower than those in the negative controls (P< 0 .05) .The levels of liver DHBV DNAin ADV treated ducks at day 30 of the treatment were significantly lower than those in the negative controls and those at baseline of treatment (P< 0 .05) .At day 15 after the termination of treatment ,the levels of liver DHBV DNA were comparable with those in the negative controls and those at baseline of treatment (P> 0 .05) .At day 30 of the treatment and day 15 after the termination of treatment ,the inhibition ratio of cccDNA in ADV treated ducks were significantly reduced as compared with those in negative con‐trols ,suggesting that ADV can effectively inhibit the replication of DHBV cccDNA .No significant change between baseline and end of treatment was observed in ALT and AST in ADV treated ducks .Conclusion ADV can effectively inhibit the replication of DHBV ,particularly ,can make DHBV cccDNA decreased .However ,when the treatment was stopped ,there was a rebound in the levels of DHBV DNA and cccDNA ,indicating that ADV should be combined with other antiviral drugs in clinical treatment and be used long‐termly .

Experimental Study on Duck Hepatitis B Virus Infection Model by Different Kinds of Ducklings and Anti-viral Effect

Primary Duck Hepatocyte Culture and Duck Hepatitis B Virus Infection Model

Anti-viral Study of a Chinese Herbal Medicine ZL-1 in Experimentally DHBV Infected Animal Model

Establishment of a hydrodynamic delivery system in ducks

Isolation and identification of duck hepatitis virus and its physical-chemical and biological characteristics

Studies on the inactivation of virus in blood components by using DHBV infected animal model

The Pathogenicity of Duck Hepatitis A Virus Types 1 and 3 on Ducklings.

Advances in the Duck Hepatitis A virus and lessons learned from those in recent years

Proteomic Analysis of Primary Duck Hepatocytes Infected with Duck Hepatitis B Virus

[Combination of Lamivudine with Thymosin Alpha1 in Treatment of Duck Hepatitis B].

Research of adefovir dipivoxil against duck hepatitis B virus cccDNA

A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009-2021

Effect of Total Phenolics Acid of Oenanthe Javanica on the Duck Hepatitis B

Duck Hepatitis A Virus 1 Has Lymphoid Tissue Tropism Altering the Organic Immune Responses of Mature Ducks.

Transbody Against Virus Core Protein Potently Inhibits Hepadnavirus Replication in Vivo: Evidence from A Duck Model of Hepatitis B Virus

Isolation and Identification of Paramyxovirus Causing duck Egg Drop

Comparative pathogenicity of duck hepatitis A virus genotype 3 in different duck breeds: Implications of the diagnosis and prevention of duck viral hepatitis

Transcriptomic Characterization of a Chicken Embryo Model Infected With Duck Hepatitis A Virus Type 1.

Mutations In Vp0 And 2c Proteins Of Duck Hepatitis A Virus Type 3 Attenuate Viral Infection And Virulence

Inhibition of Binding Peptides on Replication of Duck Hepatitis B Virus

Elimination of Immune Tolerance to Hepatitis Virus in an Animal Model.